SELECTIVE ADSORBENT OF EDA (+) FIBRONECTIN

One of the important purposes of apheresis in immune diseases is to remove EDA (+) fibronectin, which becomes elevated in the plasma of patients with serious rheumatoid arthritis, SLE, and rejection of kidney graft. We developed EDA (+) fibronectin adsorbent (OHC-10), but as described previously, it...

Full description

Saved in:
Bibliographic Details
Published inJinko Zoki Vol. 28; no. 1; pp. 118 - 122
Main Authors Tamaki, Tohru, Konoeda, Yoshiki, Sakashita, Eiji, Kawamura, Akio, Meguro, Jun-ichi, Tanaka, Mitsuko, Kukita, Kazutaka, Yonekawa, Motoki
Format Journal Article
LanguageJapanese
Published JAPANESE SOCIETY FOR ARTIFICIAL ORGANS 01.01.1999
一般社団法人 日本人工臓器学会
Subjects
Online AccessGet full text
ISSN0300-0818
1883-6097
DOI10.11392/jsao1972.28.118

Cover

More Information
Summary:One of the important purposes of apheresis in immune diseases is to remove EDA (+) fibronectin, which becomes elevated in the plasma of patients with serious rheumatoid arthritis, SLE, and rejection of kidney graft. We developed EDA (+) fibronectin adsorbent (OHC-10), but as described previously, it adsorbed not only EDA (+) fibronectin but also AT III and lipids. We recently developed a new adsorbent (OHC-20) which dose not adsorb AT III. Using 1 ml of OHC-20, a single pass test of 40ml blood was performed in 3 volunteers. Reduction rates were calculated for EDA (+) fibronectin, AT III, fibrinogen, cholesterol, triglyceride, and platelets. The reduction rate of EDA (+) fibronectin was more than 40%. One ml of OHC-20 could adsorb EDA (+) fibronectin in more than 40ml of blood. The reduction rate of AT III was less than 10%. Cholesterol and triglyceride were adsorbed to only a small degree. OHC-20 might be practical for the reduction of EDA (+) fibronectin.
ISSN:0300-0818
1883-6097
DOI:10.11392/jsao1972.28.118